Heron Therapeutics
HRTX
#7580
Rank
NZ$0.47 B
Marketcap
$3.10
Share price
0.00%
Change (1 day)
-32.56%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.97. In 2022 the company made an earnings per share (EPS) of -$2.91 an increase over its 2021 EPS that were of -$3.79.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-33.45%
2022-$2.91-23.11%
2021-$3.79-10%
2020-$4.21-0%
2019-$4.211.21%
2018-$4.16-32.7%
2017-$6.17-19.34%
2016-$7.6554.76%
2015-$4.951.73%
2014-$4.86-16.23%
2013-$5.8091.67%
2012-$3.03-31.45%
2011-$4.42-27.06%
2010-$6.06-43.75%
2009-$10.77-57.33%
2008-$25.24-82.92%
2007-$147.7220.61%
2006-$122.48175.76%
2005-$44.42-21.43%
2004-$56.53100%
2003-$28.26-38.24%
2002-$45.76161.54%
2001-$17.50-106.46%
2000$270.692051.55%
1999$12.58839.73%
1998$1.34-105.48%
1997-$24.45-88.16%
1996-$206.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.19-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.24-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.74 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.64-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.78 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA